dr holst glp-1 Dr. Jens Juul Holst: in Modern Medicine | Ep. 03 - The GLP-1 Podcast Show - Podcast Episode Jens Juul Holst: physician-scientist and

The Miller School of Medicine's Dr

Please repost and share to help a fellow pharma professional!

That is a real risk employers, health plans, and patients need to confront

And we offer real flexibility on how you fund it: - Traditional cost share - Defined contribution offerings - Manufacturer-direct cash pay Were also proud to be the only solution with published 4-year outcomes using GLPs across every workforce type: office, shift, field, and more

The findings revealed a crucial insight, for some GLP-1 s like Saxenda and Wegovy, the high cost of ongoing use surpasses the cost of RYGB in less than a year and sleeve gastrectomy within nine months

GLP-1 receptor agonists including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have become perhaps the most talked-about medications in medicine